BERRY CORP (BRY)

US08579X1019 - Common Stock

3.79  -0.01 (-0.26%)

After market: 3.79 0 (0%)

Fundamental Rating

4

Overall BRY gets a fundamental rating of 4 out of 10. We evaluated BRY against 205 industry peers in the Oil, Gas & Consumable Fuels industry. While BRY is still in line with the averages on profitability rating, there are concerns on its financial health. BRY may be a bit undervalued, certainly considering the very reasonable score on growth



4

1. Profitability

1.1 Basic Checks

In the past year BRY was profitable.
BRY had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BRY reported negative net income in multiple years.
Each year in the past 5 years BRY had a positive operating cash flow.

1.2 Ratios

BRY has a Return On Assets of 5.51%. This is comparable to the rest of the industry: BRY outperforms 51.96% of its industry peers.
BRY has a Return On Equity (11.41%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 12.12%, BRY is in the better half of the industry, outperforming 76.96% of the companies in the same industry.
Industry RankSector Rank
ROA 5.51%
ROE 11.41%
ROIC 12.12%
ROA(3y)5.54%
ROA(5y)0.14%
ROE(3y)11.32%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 9.40%, BRY perfoms like the industry average, outperforming 42.16% of the companies in the same industry.
In the last couple of years the Profit Margin of BRY has declined.
Looking at the Operating Margin, with a value of 27.17%, BRY is in line with its industry, outperforming 57.35% of the companies in the same industry.
BRY's Operating Margin has declined in the last couple of years.
BRY's Gross Margin of 60.68% is fine compared to the rest of the industry. BRY outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of BRY has declined.
Industry RankSector Rank
OM 27.17%
PM (TTM) 9.4%
GM 60.68%
OM growth 3Y11.4%
OM growth 5Y-15.2%
PM growth 3YN/A
PM growth 5Y-13.17%
GM growth 3Y-7.51%
GM growth 5Y-5.5%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRY is creating some value.
Compared to 1 year ago, BRY has about the same amount of shares outstanding.
The number of shares outstanding for BRY has been reduced compared to 5 years ago.
The debt/assets ratio for BRY is higher compared to a year ago.

2.2 Solvency

BRY has an Altman-Z score of 1.36. This is a bad value and indicates that BRY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BRY (1.36) is comparable to the rest of the industry.
BRY has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as BRY would need 2.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.92, BRY is in the better half of the industry, outperforming 71.57% of the companies in the same industry.
A Debt/Equity ratio of 0.54 indicates that BRY is somewhat dependend on debt financing.
BRY has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.92
Altman-Z 1.36
ROIC/WACC1.51
WACC8%

2.3 Liquidity

BRY has a Current Ratio of 0.80. This is a bad value and indicates that BRY is not financially healthy enough and could expect problems in meeting its short term obligations.
BRY's Current ratio of 0.80 is on the low side compared to the rest of the industry. BRY is outperformed by 71.57% of its industry peers.
A Quick Ratio of 0.70 indicates that BRY may have some problems paying its short term obligations.
BRY has a worse Quick ratio (0.70) than 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.7

4

3. Growth

3.1 Past

BRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.30%.
The Earnings Per Share has been decreasing by -4.28% on average over the past years.
Looking at the last year, BRY shows a quite strong growth in Revenue. The Revenue has grown by 11.42% in the last year.
BRY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)-55.3%
EPS 3Y-4.27%
EPS 5Y-4.28%
EPS Q2Q%-6.67%
Revenue 1Y (TTM)11.42%
Revenue growth 3Y19.93%
Revenue growth 5Y9.02%
Sales Q2Q%118.67%

3.2 Future

BRY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.04% yearly.
Based on estimates for the next years, BRY will show a decrease in Revenue. The Revenue will decrease by -1.38% on average per year.
EPS Next Y19.85%
EPS Next 2Y6.36%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue Next Year-7.07%
Revenue Next 2Y-6.02%
Revenue Next 3Y-1.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.42, the valuation of BRY can be described as very cheap.
Based on the Price/Earnings ratio, BRY is valued a bit cheaper than 79.41% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.73, BRY is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.70, the valuation of BRY can be described as very cheap.
Based on the Price/Forward Earnings ratio, BRY is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
BRY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 6.42
Fwd PE 6.7

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRY is valued cheaper than 97.55% of the companies in the same industry.
97.06% of the companies in the same industry are more expensive than BRY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2
EV/EBITDA 1.72

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BRY's earnings are expected to grow with 13.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y6.36%
EPS Next 3Y13.04%

4

5. Dividend

5.1 Amount

BRY has a Yearly Dividend Yield of 3.16%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of BRY has falen by -29.94%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 7.08, BRY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, BRY pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

The dividend of BRY is nicely growing with an annual growth rate of 35.10%!
BRY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)35.1%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

74.93% of the earnings are spent on dividend by BRY. This is not a sustainable payout ratio.
BRY's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP74.93%
EPS Next 2Y6.36%
EPS Next 3Y13.04%

BERRY CORP

NASDAQ:BRY (12/20/2024, 8:00:01 PM)

After market: 3.79 0 (0%)

3.79

-0.01 (-0.26%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/dmh
Earnings (Next)N/A N/A
Inst Owners88.67%
Inst Owner Change-2.77%
Ins Owners2.56%
Ins Owner Change-0.12%
Market Cap291.60M
Analysts73.33
Price Target6.67 (75.99%)
Short Float %2.06%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Dividend Growth(5Y)35.1%
DP74.93%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-15 2024-11-15 (0.03)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.9%
Min EPS beat(2)-11.77%
Max EPS beat(2)-6.02%
EPS beat(4)0
Avg EPS beat(4)-20.88%
Min EPS beat(4)-45.37%
Max EPS beat(4)-6.02%
EPS beat(8)2
Avg EPS beat(8)94.34%
EPS beat(12)4
Avg EPS beat(12)62.89%
EPS beat(16)6
Avg EPS beat(16)58.1%
Revenue beat(2)2
Avg Revenue beat(2)26.33%
Min Revenue beat(2)10.55%
Max Revenue beat(2)42.11%
Revenue beat(4)3
Avg Revenue beat(4)22.42%
Min Revenue beat(4)-26.05%
Max Revenue beat(4)63.05%
Revenue beat(8)6
Avg Revenue beat(8)16.43%
Revenue beat(12)9
Avg Revenue beat(12)17.31%
Revenue beat(16)10
Avg Revenue beat(16)7.52%
PT rev (1m)-12.57%
PT rev (3m)-17.01%
EPS NQ rev (1m)-7.45%
EPS NQ rev (3m)-20.35%
EPS NY rev (1m)-8.72%
EPS NY rev (3m)-14.75%
Revenue NQ rev (1m)-3.4%
Revenue NQ rev (3m)-3.45%
Revenue NY rev (1m)4.75%
Revenue NY rev (3m)3.99%
Valuation
Industry RankSector Rank
PE 6.42
Fwd PE 6.7
P/S 0.33
P/FCF 2
P/OCF 1.18
P/B 0.4
P/tB 0.4
EV/EBITDA 1.72
EPS(TTM)0.59
EY15.57%
EPS(NY)0.57
Fwd EY14.92%
FCF(TTM)1.89
FCFY49.98%
OCF(TTM)3.22
OCFY85.02%
SpS11.55
BVpS9.52
TBVpS9.52
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.51%
ROE 11.41%
ROCE 17.95%
ROIC 12.12%
ROICexc 12.2%
ROICexgc 12.2%
OM 27.17%
PM (TTM) 9.4%
GM 60.68%
FCFM 16.39%
ROA(3y)5.54%
ROA(5y)0.14%
ROE(3y)11.32%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y26.66%
ROICexcg growth 5Y-6.06%
ROICexc growth 3Y26.66%
ROICexc growth 5Y-6.06%
OM growth 3Y11.4%
OM growth 5Y-15.2%
PM growth 3YN/A
PM growth 5Y-13.17%
GM growth 3Y-7.51%
GM growth 5Y-5.5%
F-Score9
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.92
Debt/EBITDA 0.97
Cap/Depr 60.32%
Cap/Sales 11.49%
Interest Coverage 6.99
Cash Conversion 60.33%
Profit Quality 174.43%
Current Ratio 0.8
Quick Ratio 0.7
Altman-Z 1.36
F-Score9
WACC8%
ROIC/WACC1.51
Cap/Depr(3y)78.51%
Cap/Depr(5y)104.01%
Cap/Sales(3y)16.42%
Cap/Sales(5y)21.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.3%
EPS 3Y-4.27%
EPS 5Y-4.28%
EPS Q2Q%-6.67%
EPS Next Y19.85%
EPS Next 2Y6.36%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue 1Y (TTM)11.42%
Revenue growth 3Y19.93%
Revenue growth 5Y9.02%
Sales Q2Q%118.67%
Revenue Next Year-7.07%
Revenue Next 2Y-6.02%
Revenue Next 3Y-1.38%
Revenue Next 5YN/A
EBIT growth 1Y6139.3%
EBIT growth 3Y33.6%
EBIT growth 5Y-7.55%
EBIT Next Year258.1%
EBIT Next 3Y49.43%
EBIT Next 5YN/A
FCF growth 1Y-17.33%
FCF growth 3Y3.26%
FCF growth 5YN/A
OCF growth 1Y-16.16%
OCF growth 3Y0.36%
OCF growth 5Y14.02%